Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,656 | 725 | 96.1% |
| Education | $320.11 | 4 | 2.4% |
| Gift | $200.00 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,354 | 222 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,067 | 162 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,620 | 97 | $0 (2024) |
| Janssen Biotech, Inc. | $1,220 | 55 | $0 (2024) |
| Gilead Sciences, Inc. | $423.24 | 20 | $0 (2024) |
| PFIZER INC. | $394.17 | 23 | $0 (2024) |
| QOL Medical, LLC | $392.87 | 18 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $390.55 | 24 | $0 (2023) |
| Merck Sharp & Dohme LLC | $293.11 | 13 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $237.16 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,505 | 196 | ABBVIE INC. ($1,163) |
| 2023 | $3,496 | 198 | ABBVIE INC. ($1,218) |
| 2022 | $3,467 | 179 | ABBVIE INC. ($1,113) |
| 2021 | $2,708 | 157 | AbbVie Inc. ($860.34) |
All Payment Transactions
730 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.37 | General |
| Category: Gastroenterology | ||||||
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.46 | General |
| Category: Gastroenterology | ||||||
| 12/13/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $37.69 | General |
| Category: Immunology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $37.45 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.42 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.19 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $3.93 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $4.06 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.44 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $13.43 | General |
| Category: GI | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $10.19 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 271 | 438 | $114,369 | $32,006 |
| 2022 | 5 | 371 | 476 | $104,702 | $31,177 |
| 2021 | 4 | 384 | 497 | $103,086 | $34,065 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 223 | 387 | $100,233 | $28,749 | 28.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $9,384 | $2,161 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 27 | $4,752 | $1,096 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 189 | 263 | $68,117 | $19,367 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 131 | 154 | $27,104 | $8,205 | 30.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 13 | $4,511 | $1,493 | 33.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 16 | 20 | $2,500 | $1,068 | 42.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 24 | 26 | $2,470 | $1,044 | 42.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 155 | 211 | $54,649 | $17,595 | 32.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 198 | 253 | $44,528 | $14,600 | 32.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 19 | 21 | $2,625 | $1,434 | 54.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 12 | $1,284 | $435.96 | 34.0% |
About Kimberly Smith, APN
Kimberly Smith, APN is a Acute Care healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053402339.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kimberly Smith, APN has received a total of $13,176 in payments from pharmaceutical and medical device companies, with $3,505 received in 2024. These payments were reported across 730 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($12,656).
As a Medicare-enrolled provider, Smith has provided services to 1,026 Medicare beneficiaries, totaling 1,411 services with total Medicare billing of $97,249. Data is available for 3 years (2021–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Acute Care
- Location Knoxville, TN
- Active Since 09/28/2006
- Last Updated 11/11/2022
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1053402339
Products in Payments
- XIFAXAN (Drug) $1,852
- ENTYVIO (Biological) $1,259
- RINVOQ (Biological) $1,193
- STELARA (Biological) $864.70
- LINZESS (Drug) $835.75
- SKYRIZI (Biological) $759.06
- MAVYRET (Drug) $580.89
- HUMIRA (Biological) $537.50
- ZENPEP (Drug) $493.65
- DUPIXENT (Biological) $376.60
- CREON (Drug) $314.68
- DIFICID (Drug) $293.11
- SUCRAID (Drug) $266.04
- TREMFYA (Drug) $234.42
- TRULANCE (Drug) $215.10
- RELTONE 200 MG (Drug) $214.30
- IBSRELA (Drug) $207.77
- VELSIPITY (Drug) $199.94
- XELJANZ (Drug) $194.23
- MOTEGRITY (Drug) $190.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Knoxville
Mr. Stephen Miller, Acnp, ACNP
Acute Care — Payments: $86,064
Mr. Timothy Ballard, Acnp, ACNP
Acute Care — Payments: $43,500
Dr. William Stafford, Agacnp, AGACNP
Acute Care — Payments: $4,313
Mrs. Shelley Lott, Arnp, ARNP
Acute Care — Payments: $4,000
Mrs. Frankie Cate, Acnp-Bc, ACNP-BC
Acute Care — Payments: $3,165
Kerry Hastey-Witt, Aprn, APRN
Acute Care — Payments: $2,905